Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Other Non-Current Liabilities (2018 - 2019)

Historic Other Non-Current Liabilities for Iovance Biotherapeutics (IOVA) over the last 4 years, with Q3 2019 value amounting to $53000.0.

  • Iovance Biotherapeutics' Other Non-Current Liabilities changed N/A to $53000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $53000.0, marking a year-over-year change of. This contributed to the annual value of $230000.0 for FY2018, which is N/A changed from last year.
  • Per Iovance Biotherapeutics' latest filing, its Other Non-Current Liabilities stood at $53000.0 for Q3 2019.
  • Iovance Biotherapeutics' Other Non-Current Liabilities' 5-year high stood at $230000.0 during Q4 2018, with a 5-year trough of $53000.0 in Q1 2019.